These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 27233303)
21. Oxidative stress impairs vasorelaxation induced by the soluble guanylyl cyclase activator BAY 41-2272 in spontaneously hypertensive rats. Priviero FB; Zemse SM; Teixeira CE; Webb RC Am J Hypertens; 2009 May; 22(5):493-9. PubMed ID: 19247264 [TBL] [Abstract][Full Text] [Related]
22. Soluble guanylate cyclase as an alternative target for bronchodilator therapy in asthma. Ghosh A; Koziol-White CJ; Asosingh K; Cheng G; Ruple L; Groneberg D; Friebe A; Comhair SA; Stasch JP; Panettieri RA; Aronica MA; Erzurum SC; Stuehr DJ Proc Natl Acad Sci U S A; 2016 Apr; 113(17):E2355-62. PubMed ID: 27071111 [TBL] [Abstract][Full Text] [Related]
23. Reduction of obstruction related bladder overactivity by the guanylyl cyclase modulators BAY 41-2272 and BAY 60-2770 alone or in combination with a phosphodiesterase type 5 inhibitor. Füllhase C; Hennenberg M; Sandner P; Strittmatter F; Niedworok C; Bauer RM; Gratzke C; Soler R; Stief C; Andersson KE Neurourol Urodyn; 2015 Nov; 34(8):787-93. PubMed ID: 25230878 [TBL] [Abstract][Full Text] [Related]
24. Soluble Guanylate Cyclase-Mediated Relaxation in Aortas from Rats with Renovascular Hypertension. Tawa M; Shimosato T; Nakagawa K; Okamura T; Ohkita M Pharmacology; 2022; 107(3-4):235-240. PubMed ID: 34929695 [TBL] [Abstract][Full Text] [Related]
25. Soluble Guanylate Cyclase Modulators, BAY 41-2272 and BAY 60-2770, Inhibit Human and Rabbit Prostate Contractility. Calmasini FB; Alexandre EC; Silva FH; De Nucci G; Antunes E; D'Ancona CA; Mónica FZ Urology; 2016 Aug; 94():312.e9-312.e15. PubMed ID: 27131967 [TBL] [Abstract][Full Text] [Related]
26. Effects of 5-cyclopropyl-2-[1-(2-fluoro-benzyl)-1H-pyrazolo[3,4-b]pyridine-3-yl]pyrimidin-4-ylamine (BAY 41-2272) on smooth muscle tone, soluble guanylyl cyclase activity, and NADPH oxidase activity/expression in corpus cavernosum from wild-type, neuronal, and endothelial nitric-oxide synthase null mice. Teixeira CE; Priviero FB; Webb RC J Pharmacol Exp Ther; 2007 Sep; 322(3):1093-102. PubMed ID: 17596536 [TBL] [Abstract][Full Text] [Related]
28. Effects of peroxynitrite on relaxation through the NO/sGC/cGMP pathway in isolated rat iliac arteries. Tawa M; Shimosato T; Iwasaki H; Imamura T; Okamura T J Vasc Res; 2014; 51(6):439-46. PubMed ID: 25634663 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of the relaxant effect of the nitric oxide-independent soluble guanylyl cyclase stimulator BAY 41-2272 in isolated detrusor smooth muscle. Báu FR; Mónica FZ; Priviero FB; Baldissera L; de Nucci G; Antunes E Eur J Pharmacol; 2010 Jul; 637(1-3):171-7. PubMed ID: 20399768 [TBL] [Abstract][Full Text] [Related]
30. Mechanisms of relaxant activity of the nitric oxide-independent soluble guanylyl cyclase stimulator BAY 41-2272 in rat tracheal smooth muscle. Toque HA; Mónica FZ; Morganti RP; De Nucci G; Antunes E Eur J Pharmacol; 2010 Oct; 645(1-3):158-64. PubMed ID: 20670622 [TBL] [Abstract][Full Text] [Related]
31. The soluble guanylyl cyclase activator BAY 60-2770 ameliorates overactive bladder in obese mice. Leiria LO; Silva FH; Davel AP; Alexandre EC; Calixto MC; De Nucci G; Mónica FZ; Antunes E J Urol; 2014 Feb; 191(2):539-47. PubMed ID: 24050894 [TBL] [Abstract][Full Text] [Related]
32. The sGC activator BAY 60-2770 has potent erectile activity in the rat. Lasker GF; Pankey EA; Frink TJ; Zeitzer JR; Walter KA; Kadowitz PJ Am J Physiol Heart Circ Physiol; 2013 Jun; 304(12):H1670-9. PubMed ID: 23585129 [TBL] [Abstract][Full Text] [Related]
33. Mechanism of relaxation and interaction with nitric oxide of the soluble guanylate cyclase stimulator BAY 41-2272 in mouse gastric fundus and colon. Cosyns SM; Lefebvre RA Eur J Pharmacol; 2012 Jul; 686(1-3):104-15. PubMed ID: 22575520 [TBL] [Abstract][Full Text] [Related]
34. Heme oxygenase-1 deficiency leads to alteration of soluble guanylate cyclase redox regulation. Jones AW; Durante W; Korthuis RJ J Pharmacol Exp Ther; 2010 Oct; 335(1):85-91. PubMed ID: 20605906 [TBL] [Abstract][Full Text] [Related]
35. Soluble guanylate cyclase activator BAY 54-6544 improves vasomotor function and survival in an accelerated ageing mouse model. Ataei Ataabadi E; Golshiri K; Jüttner AA; de Vries R; Van den Berg-Garrelds I; Nagtzaam NMA; Khan HN; Leijten FPJ; Brandt RMC; Dik WA; van der Pluijm I; Danser AHJ; Sandner P; Roks AJM Aging Cell; 2022 Sep; 21(9):e13683. PubMed ID: 36029161 [TBL] [Abstract][Full Text] [Related]